Press Releases : Catalyst Pharmaceutical

Year

Date	Title and Summary	Additional Formats
Jan 10, 2022	Catalyst Pharmaceuticals Announces 11th Circuit Court of Appeals Denial of Jacobus Pharmaceutical Company Inc.'s Petition for Rehearing CORAL GABLES, Fla. , Jan. 10, 2022 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare
Jan 04, 2022	Catalyst Pharmaceuticals to Participate in January 2022 Virtual Investor Conferences CORAL GABLES, Fla. , Jan. 04, 2022 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals , Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare